The US inhalable drug market is anticipated to grow at a CAGR of 2.3% during the forecast period (2020-2026). The key factors driving the growth of the market include the rising prevalence of various respiratory and non- respiratory diseases in the country. The prevalence of asthma in the US is 1 in every 13 people. […]
Tag Archives: US Inhalable Drugs Market
The US inhalable drug market is anticipated to grow at a CAGR of 2.3% over the forecast period. The key factors that drive the growth of the industry include the increased prevalence of respiratory diseases such as asthma, COPD among others. The rising level of air pollution is one of the major factors responsible for […]
The US inhalable drug market is anticipated to grow at a CAGR of 2.3% over the forecast period. The key factors that drive the growth of the industry include the increased prevalence of respiratory diseases such as asthma, COPD among others. The rising level of air pollution is one of the major factors responsible for […]